Method and apparatus for diagnosing and treating neural dysfunction

Information

  • Patent Grant
  • 8818503
  • Patent Number
    8,818,503
  • Date Filed
    Friday, August 30, 2013
    11 years ago
  • Date Issued
    Tuesday, August 26, 2014
    10 years ago
Abstract
A method and apparatus for diagnosing and treating neural dysfunction is disclosed. This device has the capability of delivering the therapeutic electrical energy to more than one treatment electrode simultaneously. In another exemplary embodiment, this device can perform EMG testing both before and after the therapeutic energy has been delivered, to assess whether the target nerve was successfully treated. In another embodiment, the device has the capability to record and store sensory stimulation thresholds both before and after treatment is described, which allows the clinician to accurately determine whether the target nerve has been desensitized. Energy control may achieved by simultaneously comparing the tip temperature of each treatment electrode to a set temperature selected by the operator, and regulating the therapeutic energy output to maintain the set temperature. In another embodiment, EMG, stimulation thresholds, and graphs of temperature versus time can be conveniently displayed on a two-dimensional graphics display.
Description
FIELD

The presently described system relates generally to the advancement of medical technology, processes, and systems for the treatment of pain, neurological disorders, and other clinical maladies related to neural dysfunction. More specifically, the present disclosure is directed at a system for producing therapeutic lesions or tissue alterations by means of a high frequency generator connected to a patient via more than one electrode. In below-described exemplary embodiments, therapeutic energy is delivered and regulated simultaneously. Various specific exemplary embodiments of this device accommodate specific exemplary clinical applications and designs.


BACKGROUND

The general use of radiofrequency and high frequency generator systems which deliver electrical output to electrodes that are connected to a patient's body is known in the clinical literature and art.


By reference, an example of radiofrequency heat lesioning generators used in clinical practice for the treatment of neural disorders is the Radionics RFG-3C+ (Burlington Mass.).


This device is capable of delivering high frequency energy to patient tissue via an adapted electrode, and associated ground or reference electrode. This device is also capable of delivering low frequency stimulation pulses that are used to accurately localize the electrode placement before treatment.


Parameters that may be measured by these devices include impedance, HF voltage, HF current, HF power, and electrode tip temperature. Parameters that may be set by the user include time of energy delivery, desired electrode temperature, stimulation frequencies and durations, and level of stimulation output. In general, electrode temperature is a parameter that may be controlled by the regulation of high frequency output power.


These devices have various user interfaces that allow the selection of one or more of these treatment parameters, as well as various methods to display the parameters mentioned above.


In one application of these devices, a patient complains of back pain, or some other pain of nocioceptive or neuropathic origin. A doctor then performs diagnostic blocks with local anesthetic by injecting the anesthetic into the areas that is suspected of generating the pain. If the patient receives temporary relief from these injections the doctor concludes that the pain generators were in the location where he made these injections. Unfortunately, the origin of pain is poorly understood; perceived pain at a certain level in the back, for instance, can actually be created from many different and multiple sources.


Once a location has been identified, the clinician will decide to deliver high frequency energy to this location to permanently destroy the pain generator. A ground or reference plate will be placed on the patient's thigh to provide a return path for the high frequency energy. An insulated electrode with a small un-insulated tip will be placed at the expected target. Stimulation pulses will be delivered at a sensory frequency (typically 50 Hz), and a stimulation voltage will be placed on the electrode. The clinician is looking for a very low threshold of response from the patient (e.g., less than 0.5 V) to ensure that the electrode is close to the sensory nerves. They will then perform a stimulation test at a muscle motor frequency (e.g., 2 Hz), and increase the stimulation voltage output to 2 v. In this instance, they are looking for no motor response in the patient's extremities as this would indicate the electrode was too close to the motor nerves. Treatment in this area could cause paralysis. Upon successful completion of these tests, high frequency energy is typically delivered for one or more minutes, while maintaining an electrode tip temperature between 70 and 90 degrees. Alternatively, high frequency energy may be delivered for one or more minutes, but in a pulsed mode where the high frequency energy is on for a short period of time and off for a long period of time, thus not producing any appreciable heating (reference is made to commonly assigned U.S. Pat. No. 6,161,048, the entire contents of which are specifically incorporated by reference herein).


Although these treatments are successful, they have several drawbacks. In practice, most patients need treatments at several different nerve locations. This requires placing the electrode, performing the stimulation, and delivering the energy at each location and then repeating the process, thus causing a great deal of wasted time, and patient discomfort, while waiting for the energy to be delivered. Another drawback is that in spite of successful stimulation testing, the target nerve is often not destroyed resulting in no decrease of pain. The clinician is left to determine whether the target nerve has been missed, or whether the pain generator is located else where in the body.


SUMMARY

The above-described and other disadvantages of the art are overcome and alleviated by the present method and system for taking the energy output from a high frequency generator module and delivering this energy simultaneously to more than one treatment electrode. In one exemplary embodiment, the energy is regulated by a feedback mechanism such that each electrode's tip temperature is maintained to a level set by the user. This greatly reduces treatment time, providing the patient with a shorter period of discomfort as well as not wasting valuable procedure room time.


In additional exemplary embodiments, EMG measurements are displayed to allow the clinician to determine whether the target nerve has been destroyed, as well as the display of pre-treatment and post-treatment sensory stimulation thresholds to measure the degree of desensitation of the target nerve. Regarding the EMG measurements, this allows the clinician to determine whether the target nerve has been successfully treated; if it has been, then other pain generation sources need to be investigated. The capability of being able to compare pre-treatment and post-treatment sensory stimulation thresholds gives the clinician an immediate look at the immediate desensitation of the target nerve.


In accordance with one exemplary embodiment, the device receives input from a module capable of delivering both high frequency energy as well as low frequency stimulation pulses, such as between 1 and 100 Hz. The device is, in turn, connected to greater than one treatment electrode. These electrodes have temperature sensors attached to their tips, which reports the tip temperature of each electrode to the device. The device has a user interface which allows the output from the said module to be independently connected to each said electrode and also a means which connects all the electrodes simultaneously to the output of the said module. In this way, the low frequency stimulation output can be independently connected to each of the patient electrodes, and then the said electrodes can be connected simultaneously to the high frequency power source, thus permitting temperature regulation of the three electrodes simultaneously. This allows both sensory and motor stimulation testing, as well as impedance monitoring to be performed on each electrode one at a time. When the therapeutic energy is desired to be delivered, the user interface allows a means which connects all electrodes together simultaneously. The device then receives the tip temperature from each of the multiple electrodes, as well as a set temperature for each electrode that is chosen by the user. The device continually compares each of the temperatures from the electrodes to the set temperature. If the electrode tip temperature ever exceeds the set temperature, the high frequency energy is disconnected from that electrode. Similarly, if the electrode tip temperature is ever less than the set temperature, the high frequency energy is either left connected or reconnected to that electrode.


Another exemplary embodiment of this invention incorporates a graphic display, which allows EMG signals to be recorded to and displayed. An additional provision allows for a speaker and/or a headphone output so that the EMG signals can also be audibly detected and analyzed.


It should be noted that the present system and method can be incorporated into high frequency power source, or can be a stand-alone peripheral device that connects inbetween the high frequency power source and the electrodes.


For at least the reasons described above, this method and invention provides practical and clinical advantages in the treatment of pain. Additional advantages will become apparent in the detailed descriptions that follow.


The above discussed and other features and advantages of the present system will be appreciated and understood by those skilled in the art from the following detailed description and drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

Referring now to the figures, which are exemplary embodiments and wherein the like elements are numbered alike:



FIG. 1 represents a simple exemplary embodiment of the presently described system;



FIG. 2 illustrates an exemplary temperature feedback control mechanism;



FIG. 3 is a schematic illustrating an exemplary setup for how the electrode set temperature is maintained;



FIG. 4 is another exemplary embodiment showing the representation of the temperature of each of the electrodes in graphical form;



FIG. 5 is another exemplary embodiment which also illustrates the graphing of the EMG signal;



FIG. 6 is another exemplary embodiment showing one method of representing pre and post-treatment sensory stimulation thresholds; and



FIG. 7 is another exemplary embodiment showing three distinct mode selections, as well as an exemplary method for selecting each electrode individually and further an exemplary method to record sensory stimulation thresholds.





DETAILED DESCRIPTION

Referring to FIG. 1, an exemplary embodiment is illustrated. Mode select switch 20 allows the user to independently connect each electrode, each of which is identified as 60, to the high frequency power source. This permits the high frequency power source to selectively be connected to each electrode for the purpose of doing individual impedance measurements or stimulation threshold testing. An additional selection on the mode select switch allows therapeutic high frequency energy to be delivered to each electrode 60. The high frequency energy is delivered simultaneously to each electrode and the individual electrode temperatures are measured and continuously compared to the user set temperature, represented by 40 in FIG. 1. As also shown in FIG. 1, the electrodes are separate and not connected to one another. In other words, the electrodes are separate probes that each incorporate active electrode elements. The term “electrode(s)” as used alone hereinafter refers to a probe(s) having the active electrode element(s). In this embodiment the individual electrode temperatures are displayed on a two-dimensional graphics panel identified by 10 in the figure. Also within the graphics display is a representation of temperature vs. time displayed in graphic format. Indicator lights, represented by 30 in FIG. 1, indicate which electrode is active at that particular moment. In this way the user always knows which electrode is active when the mode select has been set to a particular electrode, and will also indicate during high frequency therapeutic treatment which electrodes are being activated at any given time.


It is very important to note two things from this figure—one is that to the high frequency power source that delivers the high frequency energy and/or low frequency stimulation pulses could be incorporated into this device or could be a separate stand-alone unit, with this device interposed between the high frequency power source and the electrodes. Though the figure shows this device as being AC line connected (that is requiring an electrical outlet for the unit to be plugged into), a battery-operated device may also be used.


It should also be understood that mode selection could be done in many ways and the features of this user interface could be achieved with or without displays, and could use up/down pushbuttons rather than rotatable selector knobs. For instance, mode select could individually connect each electrode to the high frequency device, and could also have a position which independently connected each electrode to any EMG measuring circuit, where the EMG signal was then displayed on a two-dimensional graphics display. An additional position on the mode select would be high frequency energy delivery where either continuous or pulsed high frequency energy was delivered simultaneously to each electrode and a feedback circuit was incorporated to maintain each electrode tip at a temperature equal to set temp.


It should also be noted there are many ergonomic manifestations of this invention and it would be possible to add additional displays, buttons, and/or indicators to allow and/or assist the operator in controlling the device. For instance, FIG. 1 has an RF on indicator light, represented by 50, which will indicate whenever high frequency energy is being delivered to the electrode outputs.



FIG. 2 is a logic control diagram indicating a basic exemplary feedback mechanism for each of the temperature control electrodes. HF power, identified as 10A in the figure, is delivered system. The temperature of the electrode receiving this HF energy, as well as the user set temperature, is measured and a decision point is reached, represented by 20A in the figure. If the electrode temperature is greater than the user set temperature, the HF power is turned off to that electrode. This action is represented by block 30A in FIG. 2. Then this process starts all over again, where the electrode temperature is once again compared to the user set temperature. Conversely, if the measured temperature for that particular electrode is less than the user set temperature the HF remains on, and again, the electrode temperature is subsequently compared to the user set temperature. In this way temperature feedback is realized, which will maintain the electrode temperature at the same level as the user set temperature.



FIG. 3 is a more detailed schematic of an exemplary feedback control mechanism. Note that this circuit is only representative of the HF energy delivery, and other connections have been omitted for clarity. As an illustration of how the circuit functions, Electrode 2 has been chosen as an example. However the same descriptions apply to Electrode 1 and Electrode 3, and in fact it should be emphasized that this embodiment permits temperature control of more than one electrode. In other words two, three, four, or more different electrodes can be controlled with this device.



10B in the figure represents Electrode 2. As can be seen by 11B, and 12B, a temperature sensor is incorporated into the electrode that reports the temperature at the electrode tip, as well as a means for applying the high frequency energy to the electrode. Temperature is reported via 21B to Control 2, identified by 30B in the figure. Control 2 also has an input identified as set temperature 20B, and compares these two signals to determine whether to open or close switch S2 (identified by 50B). It is important to note that S2 is a generic switch and can be achieved both electrically and/or mechanically and/or optically. The High Frequency energy in, represented by 40B in the figure, is therefore connected and disconnected to Electrode 2 via switch S2. As switch S2 is opening and closing via Control 2, (which is constantly comparing the user set temperature to the reported electrode tip temperature and determining whether to deliver HF energy to Electrode 2), a feedback circuit is established which will maintain the Electrode 2 temperature at the user set temperature.


In FIG. 4, another exemplary embodiment of the user interface is illustrated. As identified by 10D and 40D, it is clear that electrode temperature and/or other pertinent parameters need not be displayed on a two-dimensional screen. These could be represented, for instance, by LED or LCD digits. 30D again represents a two-dimensional graphics display, in this case displaying temperature. Again, a graphics display is not necessary to realize the presently described system and method. To demonstrate exemplary options for user interface, the mode selector has been represented by a series of buttons that are associated with indicator lights identified as 20D in the figure and Set temp has been identified as up/down arrows as shown by 50D. The electrode outputs have been schematically represented by 60D.


In FIG. 5, additional exemplary embodiments of the device are shown where, this time, the mode selector 20E has a position for EMG in addition to a high frequency energy delivery position. On the two-dimensional display, an EMG signal can be represented, thus identifying electrophysiological activity of a nerve before and/or after the high frequency treatment. For completeness, 60E identifies the electrode outputs, were once again three have been illustrated, although any number greater than 1 is possible with the present system and method. The Set temp user interface has been represented in this diagram as a knob 50E, though as mentioned earlier there are other contemplated ways to achieve this user interface. 40E identifies the actual set temperature. 10E is indicating that the temperature displays of the electrodes (--) is not relevant since they would indicate body temperature (37 C), though this temperature could be displayed if desired.



FIG. 6 is an exemplary embodiment showing a sensory stimulation graph 30F, being displayed on the device. In this particular diagram, each electrode has associated with it a thin line and a fat line 35F indicating pre- and post-stimulation sensory thresholds for each electrode. Again, there are many contemplated ways that these parameters could be represented, and this is just an example of one of many ways in which to achieve a representation of these parameters that are identifiable to the user. The mode select switch, identified as 20F, has settings for both high frequency energy and stimulation. The dashes (--), indicated by 10F in the figure, represent temperature, which is irrelevant in this mode, since with no energy delivery there is no therapeutic heating and all of the electrodes will be reading body temperature (which could of course be displayed. The electrode outputs, represented by 60F, once again indicate three connections though any number of electrodes greater than one should be covered within the scope of this inventions contemplated. Set temp is represented by 5F in the figure, and its associated value is represented by 40F in the figure and is depicted as a two digit display.



FIG. 7 is another exemplary embodiment. Illustrated is a mode select button, 10G, which allows the user to select between EMG, HF, and stimulate modes. When stimulate or EMG mode is selected, a digit(s) represented by 90G, indicates which electrode is selected, as in these modes it is important to select one electrode at time, and to know which electrode is selected. The electrode selection is made by the knob identified as 50G in the figure. In this particular embodiment, the user set temperature is identified as a knob indicated by 30G, and the set temperature value is represented by 80G in the figure, and is incorporated within a two-dimensional graphics display 20G. A time vs. temperature graph is indicated by 110G in the figure, and the individual electrode temperatures, if HF is selected on the mode select, is indicated by 100G in the figure. 40G once again indicates three outputs, and 70G represented by the dotted lines indicate that more than three electrodes, or less than three electrodes (as long as number of electrodes is greater than one), is contemplated. 60G identifies a log button. This button is used in stimulate mode, since the user must identify what stimulation voltage threshold is to be saved for future display.


While the disclosure has been described with reference to exemplary embodiments, it will be understood by those skilled in the art that various changes may be made and equivalents may be substituted for elements thereof without departing from the scope of the disclosure. In addition, many modifications may be made to adapt a particular situation or material to the teachings of the disclosure without departing from the essential scope thereof. Therefore, it is intended that the disclosure not be limited to the particular embodiment disclosed as the best mode contemplated for carrying out this disclosure, but that the disclosure will include all embodiments falling within the scope of the appended claims.

Claims
  • 1. A device for use in delivering therapeutic treatment energy to a plurality of nerve locations via a corresponding plurality of probes, the device configured to selectively produce power at an RF therapeutic frequency in a therapeutic mode, and to assess electrophysiological activity of a specified one of the plurality of nerve locations in an EMG mode, the device comprising: a plurality of electrode outputs, wherein each of the electrode outputs is configured to receive EMG signals from and provide RF energy to one of a plurality of probes; anda mode select user interface operably coupled to the plurality of electrode outputs and configured to enable a user to select from a plurality of settings, wherein, in an EMG mode setting of the mode select user interface, an EMG measuring circuit is selectively coupled to a single one of the plurality of electrode outputs, andin a therapeutic mode setting of the mode select user interface, power at an RF frequency is coupled to any of the plurality of electrode outputs.
  • 2. The device for use in delivering therapeutic treatment energy to a plurality of nerve locations of claim 1, wherein the mode select user interface comprises a plurality of buttons corresponding to the plurality of electrode outputs, and an indicator display comprising a plurality of indicator lights.
  • 3. The device for use in delivering therapeutic treatment energy to a plurality of nerve locations of claim 1, wherein the mode select user interface comprises a selector having at least an EMG mode position and a therapeutic mode position.
  • 4. The device for use in delivering therapeutic treatment energy to a plurality of nerve locations of claim 1, the device further comprising a plurality of temperature displays associated with the plurality of probes coupled to the plurality of the electrode outputs, each of the plurality of temperature displays configured to indicate the temperature of a corresponding one of the probes.
  • 5. The device for use in delivering therapeutic treatment energy to a plurality of nerve locations of claim 4, the device further comprising a graphical display capable of displaying a time vs temperature graph for at least one of the probes.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 13/597,897, filed Aug. 29, 2012 and titled “Method and Apparatus for Diagnosing and Treating Neural Dysfunction” , which is a continuation of U.S. patent application Ser. No. 13/185,646, filed Jul. 19, 2011 and titled “Method and Apparatus for Diagnosing and Treating Neural Dysfunction” which issued as U.S. Pat. No. 8,265,747 on Sep. 11, 2012 , which is a continuation of U.S. patent application Ser. No. 12/966,550, filed on Dec. 13, 2010, which issued as U.S. Pat. No. 8,000,785 on Aug. 16, 2011 , which is a continuation of U.S. patent application Ser. No. 12/501,074 filed on Jul. 10, 2009, which issued as U.S. Pat. No. 7,853,326 on Dec. 14, 2010 , which is a continuation of U.S. patent application Ser. No. 11/498,446 filed on Aug. 2, 2006, which issued as U.S. Pat. No. 7,574,257 on Aug. 11, 2009 , and which claims priority to U.S. Provisional Patent Application No. 60/704,849, filed on Aug. 2, 2005, the entire disclosures of which are hereby incorporated herein by reference.

US Referenced Citations (80)
Number Name Date Kind
3898991 Ikuno et al. Aug 1975 A
4907589 Cosman Mar 1990 A
5233515 Cosman Aug 1993 A
5370672 Fowler et al. Dec 1994 A
5433739 Sluijter et al. Jul 1995 A
5456682 Edwards et al. Oct 1995 A
5474558 Neubardt Dec 1995 A
5678568 Uchikubo et al. Oct 1997 A
5718701 Shai et al. Feb 1998 A
5782826 Swanson Jul 1998 A
5820568 Willis Oct 1998 A
5837001 Mackey Nov 1998 A
5868666 Okada et al. Feb 1999 A
5868737 Taylor et al. Feb 1999 A
5871481 Kannenberg et al. Feb 1999 A
5951546 Lorentzen Sep 1999 A
5983141 Sluijter et al. Nov 1999 A
6006129 Watson Dec 1999 A
6014581 Whayne et al. Jan 2000 A
6056745 Panescu et al. May 2000 A
6074213 Hon Jun 2000 A
6117127 Helmreich et al. Sep 2000 A
6123702 Swanson et al. Sep 2000 A
6146380 Racz et al. Nov 2000 A
6161048 Sluijter et al. Dec 2000 A
6212426 Swanson Apr 2001 B1
6231569 Bek et al. May 2001 B1
6246912 Sluijter et al. Jun 2001 B1
6251113 Appelbaum et al. Jun 2001 B1
6259952 Sluijter et al. Jul 2001 B1
6312426 Goldberg et al. Nov 2001 B1
6409722 Hoey et al. Jun 2002 B1
6416520 Kynast et al. Jul 2002 B1
6440127 McGovern et al. Aug 2002 B2
6447505 McGovern et al. Sep 2002 B2
6451015 Rittman, III et al. Sep 2002 B1
6478793 Cosman et al. Nov 2002 B1
6506189 Rittman, III et al. Jan 2003 B1
6517534 McGovern et al. Feb 2003 B1
6530922 Cosman et al. Mar 2003 B2
6565511 Panescu et al. May 2003 B2
6572551 Smith et al. Jun 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6678563 Fang et al. Jan 2004 B2
6692493 McGovern et al. Feb 2004 B2
6881214 Cosman et al. Apr 2005 B2
6918771 Arington et al. Jul 2005 B2
7169143 Eggers et al. Jan 2007 B2
7270659 Ricart et al. Sep 2007 B2
7282049 Orszulak et al. Oct 2007 B2
7306596 Hillier et al. Dec 2007 B2
7331956 Hovda et al. Feb 2008 B2
7344533 Pearson et al. Mar 2008 B2
RE40279 Sluijter et al. Apr 2008 E
7574257 Rittman, III Aug 2009 B2
RE41045 Sluijter et al. Dec 2009 E
7819869 Godara et al. Oct 2010 B2
7824404 Godara et al. Nov 2010 B2
8126562 Fowler et al. Feb 2012 B2
20020177882 DiLorenzo Nov 2002 A1
20030032951 Rittman, III et al. Feb 2003 A1
20050113703 Farringdon et al. May 2005 A1
20050113730 Runeman et al. May 2005 A1
20050192546 Griego et al. Sep 2005 A1
20050192564 Cosman et al. Sep 2005 A1
20050277918 Shah et al. Dec 2005 A1
20060085054 Zikorus et al. Apr 2006 A1
20060095103 Eggers et al. May 2006 A1
20060282139 Weintraub Dec 2006 A1
20060289528 Chiu et al. Dec 2006 A1
20070043405 Rittman, III Feb 2007 A1
20070100278 Frei et al. May 2007 A1
20070118109 Baker et al. May 2007 A1
20070142873 Esteller et al. Jun 2007 A1
20070142875 Shalev et al. Jun 2007 A1
20070250119 Tyler et al. Oct 2007 A1
20080004615 Woloszko et al. Jan 2008 A1
20080009847 Ricart et al. Jan 2008 A1
20080046012 Covalin et al. Feb 2008 A1
20080287944 Pearson et al. Nov 2008 A1
Foreign Referenced Citations (14)
Number Date Country
0 908 156 Apr 1999 EP
1 493 397 Jan 2005 EP
1493397 Jan 2005 EP
2 234 136 Jun 2005 ES
WO 8501213 Mar 1985 WO
WO 9400188 Jan 1994 WO
WO 9713550 Apr 1997 WO
WO 9749453 Dec 1997 WO
WO 0112089 Feb 2001 WO
WO 2004067085 Aug 2004 WO
WO 2006092021 Sep 2006 WO
WO 2006099462 Sep 2006 WO
WO 2006119467 Nov 2006 WO
WO 2006134598 Dec 2006 WO
Non-Patent Literature Citations (18)
Entry
European Patent Office, Official Communication enclosing Search Report, EP 10 167 389.5, dated Nov. 11, 2010, 6 pages.
European Search Report; Application No. 10183821.7-2305, dated Mar. 10, 2011, 6 pages.
European Patent Office, Examination Report of Jul. 10, 2009, Application No. 06 117 004.9-2305.
Reply to Examination Report, Application No. 006 117 004.9; filed Jan. 13, 2010.
European Patent Office, Communication Under Rule 71(3) EPC; Application No. 06 117 004.9-2305; Feb. 18, 2010.
Cosman, et al., “Method of Making Nervous System Lesions, in Wilkins RH, Rengachary SS” (eds); (1984); Neurosurgery, vol. III; pp. 2490-2498.
Cosman, et al, “Theoretical Aspects of Radiofrequency Lesions and the Dorsal Root Entry Zone”; (1984); Neurosurgery; 15: pp. 945-950.
Salkoff, “Temperature-induced seizure and frequency-dependent neuromuscular block in a ts mutant Drosophilia;” (1978); Nature (UK); 273, No. 5658: pp. 156-158.
Guttman, et al, “Squid axon membrane response to white noise stimulation;” (1974); Biophys. J. (USA); 14, No. 12: pp. 941-955.
European Patent Office, European Search Report and Opinion for European Patent Application No. 06117344.9, mailed Feb. 4, 2008.
European Patent Office, European Search Report and Opinion for European Patent Application No. 06117344.9, mailed Oct. 21, 2008.
European Patent Office, Examination Report for European Patent Application No. 06117004.9, mailed Aug. 4, 2008.
European Patent Office, Examination Report for European Patent Application No. 06117004.9, mailed Jul. 24, 2007.
European Patent Office, European Search Report and Opinion for European Patent Application No. 06117004.9, mailed Sep. 22, 2006.
US Patent and Trademark Office, Official Action for U.S. Appl. No. 11/498,446, mailed Nov. 26, 2008.
US Patent and Trademark Office, Official Action for U.S. Appl. No. 11/498,446, mailed Feb. 26, 2009.
US Patent and Trademark Office, Notice of Allowance for U.S. Appl. No. 11/498,446, mailed Jun. 12, 2009.
US Patent and Trademark Office, Official Action for U.S. Appl. No. 11/506,748, mailed Aug. 20, 2009.
Related Publications (1)
Number Date Country
20140005747 A1 Jan 2014 US
Provisional Applications (1)
Number Date Country
60704849 Aug 2005 US
Continuations (5)
Number Date Country
Parent 13597897 Aug 2012 US
Child 14015345 US
Parent 13185646 Jul 2011 US
Child 13597897 US
Parent 12966550 Dec 2010 US
Child 13185646 US
Parent 12501074 Jul 2009 US
Child 12966550 US
Parent 11498446 Aug 2006 US
Child 12501074 US